Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Dry Eye > Dry eye disease comparable to other severe chronic disorders
  • Dry Eye

Dry eye disease comparable to other severe chronic disorders

Ophthalmology 360

Dry eye disease (DED) is linked to substantially impaired work functioning and its impact is comparable to that of other severe chronic disorders, such as obstructive sleep apnea syndrome and depression, according to a presentation at ARVO 2022.

“This highlights the importance of recognizing DED as a severe disorder and providing a diagnosis,” the study authors noted.

To assess the relationship between DED and work functioning, unemployment, absenteeism, and worry about job loss, researchers analyzed data from 89,215 participants in the Dutch population-based Lifelines cohort. DED was classified as a clinical diagnosis of dry eye or both dryness and irritation symptoms often or constantly present. Work functioning was assessed in 36,399 working participants.

DED was noted in 9.1% of participants with 8.5% having a previous clinical diagnosis and 1.9% had highly symptomatic dry eye.

Overall, 49.4% of patients with DED had impaired overall work functioning compared to 41.1% of those without DED (OR 1.24, 95% CI 1.14-1.35, P = 0.002, corrected for age, sex, body mass index, income, education, smoking, and 48 comorbidities associated with dry eye).

There was only a slight increase in absenteeism in the participants with DED (OR 1.10, 95% CI 1.01-1.20, P= 0.04). There was a similar risk of impaired work functioning in participants with DED as with rheumatoid arthritis and COPD, and patients with highly symptomatic dry eye had impaired work functioning at the same level as of obstructive sleep apnea syndrome and depression.

Reference
Vehof J, et al. The work-related burden of dry eye disease. Presented at: ARVO 2022.

Share

Related Content

  • Dry Eye

Spotlight on LACRIFILL®

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

  • Retina

Switching to aflibercept 8 mg extends treatment intervals in suboptimal nARMD responders

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon